In the pharmaceutical arena, we are considered to provide premium
market access strategy consultation and support.
We focus on providing excellent service and solutions that are tailored
to meet the unique needs of our clients, in such areas as:
- Strategic guidance to biopharma / pharmaceutical firms
- Government - manufacturer negotiations
- Pharmaceutical Policy Development
Market Access Solutions was established in 2001 to provide excellence in reimbursement strategy and service to the Pharmaceutical industry.
We work with corporate and government clients to resolve complex market access strategy and policy issues.
Our Team:
- We work with a select group of highly qualified individuals. Staffing for each project is tailored to meet each client's unique needs, issues, and timelines.
Our Committment:
- We provide each client with superior service and quality results.
What sets us apart is our experience-based understanding of government, industry & patient challenges. We effectively manage all aspects of Canadian market access, from early global strategic planning to the design of Phase 4 data collection programs to facilitate or improve coverage.
- We are experienced in a diversity of access issues across a broad spectrum of therapeutic areas, such as Oncology, Infectious Disease, Neurology, Dermatology, Gastrointestinal, Endocrinology, Respiratory, Bone, Cardiovascular, Biologics, Novel Delivery Systems, Rare Disease Therapies, and many other highly specialized products.
- We approach product coverage from the payer perspective, and work to provide our clients with consistent messaging and strategies. We specialize in achieveing optimal coverage for new pharmaceuticals, including specialty pharmaceuticals, biologics, and genetically-based therapies.